Effectiveness of Continuous Glucose Monitoring on Short-Term, In-Hospital Mortality Among Frail and Critically Ill Patients With COVID-19: Randomized Controlled Trial.

ABSTRACT:

Background

The use of continuous glucose monitoring (CGM) in the hospital setting is growing, with more patients using these devices at home, especially during the COVID-19 pandemic. Frail and critically ill patients with COVID-19 and previously normal glucose tolerance are also associated with variability in their glucose levels during their intensive care unit (ICU) stay. However, very limited evidence supports the use of CGM in ICU settings, especially among frail patients with COVID-19.

Objective

We aimed to investigate the effectiveness of CGM on ICU-related outcomes among frail and critically ill patients with confirmed COVID-19.

Methods

This was an exploratory, prospective, open-label, parallel, single-center, randomized controlled trial. A total of 124 patient

SUBMITTER: Shang J 

PROVIDER: S-EPMC11845876 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature